Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells.
van Der Velden VH, te Marvelde JG, Hoogeveen PG, Bernstein ID, Houtsmuller AB, Berger MS, van Dongen JJ. van Der Velden VH, et al. Among authors: van dongen jj. Blood. 2001 May 15;97(10):3197-204. doi: 10.1182/blood.v97.10.3197. Blood. 2001. PMID: 11342449 Free article. Clinical Trial.
Low frequency of reverse transcription polymerase chain reaction-detectable chromosome aberrations in relapsed acute myeloid leukaemia: implications for detection of minimal residual disease.
van der Velden VH, Schoch C, Langerak AW, Schnittger S, Hoogeveen PG, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj. Br J Haematol. 2001 Jun;113(4):1082-3. doi: 10.1046/j.1365-2141.2001.02821-7.x. Br J Haematol. 2001. PMID: 11442511 Free article. No abstract available.
Clearance of maternal leukaemic cells in a neonate.
van der Velden VH, Willemse MJ, Mulder MF, Szczepański T, Langerak AW, Wijkhuijs JM, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj. Br J Haematol. 2001 Jul;114(1):104-6. doi: 10.1046/j.1365-2141.2001.02914.x. Br J Haematol. 2001. PMID: 11472352 Free article.
T-lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies.
van Wering ER, van der Linden-Schrever BE, van der Velden VH, Szczepański T, van Dongen JJ. van Wering ER, et al. Among authors: van der velden vh, van der linden schrever be, van dongen jj. Leukemia. 2001 Aug;15(8):1301-3. doi: 10.1038/sj.leu.2402184. Leukemia. 2001. PMID: 11480575 No abstract available.
Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia.
van der Velden VH, Joosten SA, Willemse MJ, van Wering ER, Lankester AW, van Dongen JJ, Hoogerbrugge PM. van der Velden VH, et al. Among authors: van dongen jj, van wering er. Leukemia. 2001 Sep;15(9):1485-7. doi: 10.1038/sj.leu.2402198. Leukemia. 2001. PMID: 11516112 No abstract available.
Minimal residual disease in leukaemia patients.
Szczepański T, Orfão A, van der Velden VH, San Miguel JF, van Dongen JJ. Szczepański T, et al. Among authors: van der velden vh, van dongen jj. Lancet Oncol. 2001 Jul;2(7):409-17. doi: 10.1016/s1470-2045(00)00418-6. Lancet Oncol. 2001. PMID: 11905735 Review.
Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.
van der Velden VH, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj, van der schoot ce, van wering er. Leukemia. 2002 May;16(5):928-36. doi: 10.1038/sj.leu.2402475. Leukemia. 2002. PMID: 11986956
254 results